CIK 0001816736
- Large accelerated filer
Disc Medicine, Inc.
Sign in to watch- Ticker
- IRON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 851612845
- Phone
- +1 617-674-9274
- Business address
- 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
- Former names
- Gemini Therapeutics, Inc. /DE, FS Development Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,877,065
- in 6 filings, $10.0M under 10b5-1 plans
Net −$11,877,065. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-29 | GEMAYEL GEORGES Director | Grant or award · Stock Option (Right to Buy) | +7,000 | 7,000 | ||
| 2022-12-29 | MacDonald Brian Richard Chief Innovation Officer | Grant or award · Stock Option (Right to Buy) | +33,847 | 33,847 | ||
| 2022-12-29 | Chin Mark Director | Grant or award · Stock Option (Right to Buy) | +7,000 | 7,000 | ||
| 2022-12-29 | Khara Rahul General Counsel | Grant or award · Stock Option (Right to Buy) | +28,770 | 28,770 | ||
| 2022-12-29 | Yu Jonathan Yen-Wen Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +33,847 | 33,847 | ||
| 2022-12-29 | Ratcliffe Liam Director | Grant or award · Stock Option (Right to Buy) | +7,000 | 7,000 | ||
| 2022-12-29 | Bryce Joanne Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +33,847 | 33,847 | ||
| 2022-12-29 | Savage William Jacob Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +38,924 | 38,924 | ||
| 2022-12-29 | Quisel John D Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +132,002 | 132,002 | ||
| 2022-12-29 | Backstrom Jay T. Director | Grant or award · Stock Option (Right to Buy) | +7,000 | 7,000 | ||
| 2022-12-29 | White William Richard Director | Grant or award · Stock Option (Right to Buy) | +7,000 | 7,000 | ||
| 2022-10-26 | Leonard Braden Michael 10% owner | Sale | −22,500 | $2.09 | $47K | 247,500 |
| 2022-05-31 | Piekos Brian CFO | Grant or award | +9,960 | $1.09 | $11K | 17,615 |
| 2022-04-13 | Leonard Braden Michael 10% owner | Purchase | +191,769 | $1.52 | $292K | 5,000,000 |
| 2022-04-12 | Leonard Braden Michael 10% owner | Purchase | +55,000 | $1.37 | $75K | 270,000 |
| 2022-04-12 | Leonard Braden Michael 10% owner | Purchase | +203,744 | $1.42 | $290K | 4,808,231 |
| 2022-04-11 | Leonard Braden Michael 10% owner | Purchase | +504,487 | $1.35 | $681K | 4,604,487 |
| 2021-10-04 | Ong Tuyen Director | Grant or award · Stock Option (Right to Buy) | +15,528 | 15,528 | ||
| 2021-03-12 | Lubner David Charles Director | Grant or award · Stock Option (Right to Buy) | +17,529 | 17,529 |
Page 32 of 32 · 639 trades